-
-
-
-
-
-
-
Tetra Bio-Pharma Acquires Exclusive Global Technology Rights to a Mucoadhesive Delivery Technology Called Adversa(R) for its PPP-002 (dronabinol) drug candidate from IntelGenx
-
-
-
-
-
-
-
Tetra Bio-Pharma Announces Overnight Marketed Offering
-
-
-
-
-
-
-
Tetra Bio-Pharma’s Management Provides Corporate Update Ahead of Annual General Meeting
-
-
-
-
-
-
-
Tetra Bio-Pharma Enters into Binding Proposal with Quantum Pharma Inc.
-
-
-
-
-
-
-
Tetra Bio-Pharma Enters into Agreement to Acquire Remaining 20% Interest in Phytopain Pharma Subsidiary
-
-
-
923,735 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All